Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein
Beta LifeScience
SKU/CAT #: BLK-00667P-100UG

Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein
Beta LifeScience
SKU/CAT #: BLK-00667P-100UG
Collections: Other recombinant proteins, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Varicella-zoster virus (strain Oka vaccine) Envelope glycoprotein E Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ser31-Tyr538. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | Q9J3M8 |
Target Symbol | Envelope glycoprotein E |
Species | Varicella-zoster virus (strain Oka vaccine) |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Ser31-Tyr538 |
Mol. Weight | The protein has a predicted MW of 58.39 kDa. Due to glycosylation, the protein migrates to 65-85 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | VZV glycoprotein E (gE) is most abundantly expressed on the surface of infected cells, and is an essential component for virus replication and cell-to-cell transmission. It is also the main target of virus-specific antibodies and T cell responses that is often selected as vaccine candidate antigen. |